Wanbury Profit & Loss Annual

Trade
BSE: 524212 | NSE: WANBURY | ISIN: INE107F01022 | Sector: Biotechnology & Drugs
223.10 +4.35 (1.99%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 575.65499.65511.19392.52
Total Revenue 575.65499.65511.19392.52
Costof Revenue Total 302.63323.18300.29217.15
Gross Profit 273.02176.47210.90175.37
Selling/ General/ Admin Expenses Total 86.9286.8674.8164.15
Depreciation/ Amortization 13.0312.3811.459.75
Unusual Expense( Income) -25.560.59-76.37-
Other Operating Expenses Total 116.0965.71100.7793.20
Total Operating Expense 493.12488.72410.96384.25
Operating Income 82.5310.93100.238.27
Interest Inc( Exp) Net- Non- Op Total -291.81-220.64-206.11-230.75
Other Net 2.990.911.512.40
Net Income Before Taxes 56.34-10.2981.13-12.41
Provisionfor Income Taxes 0.380.11-0.350.20
Net Income After Taxes 55.96-10.4081.47-12.61
Net Income Before Extra Items 55.96-10.4081.47-12.61
Net Income 55.96-10.4081.47-12.61
Income Availableto Com Excl Extra Ord 55.96-10.4081.47-12.61
Income Availableto Com Incl Extra Ord 55.96-10.4081.47-12.61
Diluted Net Income 55.96-10.4081.47-12.61
Diluted Weighted Average Shares 3.273.273.232.50
Diluted EPS Excluding Extra Ord Items 17.10-3.1825.21-5.04
Diluted Normalized EPS 9.34-3.059.85-5.04
Gain( Loss)on Saleof Assets --0.61-0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts